Successful treatment of a female with chronic pseudo-intestinal obstruction with sympathomimetic amines and thyroid hormone replacement.

Clin Exp Obstet Gynecol

The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden, Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology, Division of Reproductive Endocrinology & Infertility, Camden, NJ, USA.

Published: December 2010

Purpose: To determine if a defect in sympathomimetic amines, which is a common cause of various undiagnosed pain syndromes in women could be the cause of chronic pseudointestinal obstruction. Furthermore to determine if this life-threatening illness may similarly respond to sympathomimetic amines as in other pain syndromes, e.g., pelvic pain and interstitial cystitis.

Method: A 23-year-old, five foot, female with chronic pseudointestinal obstruction, who lost 35 pounds down to 75 pounds, was treated with 15 mg dextroamphetamine sulfate and 50 microg of L-thyroxin (her TSH thyroid hormone level was markedly suppressed in the face of a slightly low free thyroxin level.

Results: Her abdominal pain lessened then completely disappeared within a few weeks. Within one year she gained 25 pounds.

Conclusions: Chronic pseudointestinal obstruction is another way idiopathic orthostatic edema (a condition found predominantly in women) may manifest. Similar to other gastrointestinal pain syndromes and pain in other areas, e.g., pelvis, bladder, head and joints, treatment with sympathomimetic amines results in dramatic improvement.

Download full-text PDF

Source

Publication Analysis

Top Keywords

sympathomimetic amines
16
pain syndromes
12
chronic pseudointestinal
12
pseudointestinal obstruction
12
female chronic
8
thyroid hormone
8
pain
6
successful treatment
4
treatment female
4
chronic
4

Similar Publications

Impact of Norepinephrine Use on Free Flap Survival in Breast Reconstructive Microsurgery.

Microsurgery

January 2025

Service de Chirurgie Plastique et Reconstructrice, Hôpital européen Georges-Pompidou, Paris, France.

Objective: The optimal method for maintaining intraoperative blood pressure during microsurgical procedures remains controversial. While intravenous fluid administration is essential, overfilling can lead to complications. Vasopressor agents are used cautiously due to their vasoconstrictive effects, which could potentially lead to flap failure.

View Article and Find Full Text PDF

Catalytically active nanomaterials, or nanozymes, have gained significant attention as alternatives to natural enzymes due to their low cost, ease of preparation, and enhanced stability. Because of easy preparation, excellent biocompatibility, and unique optoelectronic properties, gold nanoparticles (AuNPs) have attracted increasing attention in many fields, including nanozymes. In this work, we demonstrated the applicability of beta-cyclodextrin functionalized gold nanoparticles (β-CD-AuNPs) as enzyme mimics for different substances, including TMB and DA.

View Article and Find Full Text PDF

Elevated dopamine (DA) levels in urine denote neuroblastoma, a pediatric cancer. Saccharide-derived carbon dots (CDs) were applied to assay DA detection in simulated urine (SU) while delineating the effects of graphene defect density on electrocatalytic activity. CDs were hydrothermally synthesized to vary graphene defect densities using sucrose, raffinose, and palatinose, depositing them onto glassy carbon electrodes (GCEs).

View Article and Find Full Text PDF

This paper summarizes the main findings of a study which aimed to examine the electrochemical oxidation of homovanillic acid (HVA), the final metabolite of dopamine. A pencil graphite electrode (PGE) was used as working electrode and the measurements were performed by cyclic voltammetry (CV) and differential pulse voltammetry (DPV). The type and the composition of the graphite leads used as PGE, the pH of the supporting electrolyte, as well as the scan rates were optimized by CV.

View Article and Find Full Text PDF

Glucagon can increase the force of contraction (FOC) in, for example, canine hearts. Currently, whether glucagon can also increase the FOC via cAMP-increasing receptors in the human atrium is controversial discussed. Glucagon alone did not (up to 1 µM) raise the FOC in human right atrial preparations (HAP).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!